Bloomberg Law
June 1, 2018, 1:03 PM

Right-To-Try Author Says Law’s Intent Is to Diminish FDA’s Power

Anna Edney
Anna Edney
Bloomberg News

Senator Ron Johnson, the chief sponsor of a new law giving terminally ill patients easier access to experimental drugs, said the aim of the measure is to weaken the U.S. Food and Drug Administration.

In a letter to FDA Commissioner Scott Gottlieb on Thursday, the Wisconsin Republican said the goal is to “diminish the FDA’s power over people’s lives, not increase it.”

The blunt message came a day after President Donald Trump signed the so-called right-to-try bill into law. It was in response to previous comments Gottlieb had made detailing how the agency plans to implement the law.

Gottlieb told ...